VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 43 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $20,221,500 | +93414.2% | 850,000 | 0.0% | 1.13% | -20.4% |
| Q1 2023 | $21,624 | -32.7% | 850,000 | -22.7% | 1.42% | -33.8% |
| Q4 2022 | $32,131 | -99.9% | 1,100,000 | -16.0% | 2.15% | +14.5% |
| Q3 2022 | $26,868,000 | +164.6% | 1,310,000 | +49.3% | 1.88% | +144.5% |
| Q2 2022 | $10,153,000 | -45.1% | 877,500 | -12.2% | 0.77% | -45.9% |
| Q1 2022 | $18,490,000 | +211.8% | 1,000,000 | +233.3% | 1.42% | +302.3% |
| Q4 2021 | $5,931,000 | +5.3% | 300,000 | -12.4% | 0.35% | +54.1% |
| Q3 2021 | $5,635,000 | -10.2% | 342,562 | -0.1% | 0.23% | +7.5% |
| Q2 2021 | $6,273,000 | -18.2% | 342,962 | -25.3% | 0.21% | +24.6% |
| Q1 2021 | $7,672,000 | – | 459,144 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |